Skip to content
Breaking
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Welcoming Three New Leaders to the CureSearch Board of Directors
A Pan-Canadian Team Develops Revolutionary Egg-Based Tumor Model for Rapid, Personalized Cancer Treatment Discovery
Estrogen Hormone Regulates Female Binge Drinking, Driving Rapid Alcohol Consumption and Contributing to Sex Differences in Behavior
Routine Calcium and Vitamin D Supplementation Offers Little Benefit Against Falls and Fractures for Most Older Adults, Major Review Concludes
The Dual Nature of a Crucial Enzyme: PI3K Possesses Both Accelerator and Brake for Cell Migration
Genetically Tailored Treatment Plans for Children with Wilms Tumour Promise More Effective Care and Minimized Side Effects
21 Sep 2026, Mon
Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Comprehensive Review Confirms Acetaminophen Use During Pregnancy Does Not Increase Risk of Autism or ADHD in Children

George Ongkojoyo Sep 14, 2026

A landmark study published in The Lancet Obstetrics, Gynaecology & Women’s Health has provided the...

Neuro-Oncology (Brain & CNS)

Unlocking Immunotherapy’s Potential: Researchers Identify Key Immune Cell "Programs" in Brain Tumors

Nana O Sep 14, 2026

Immunotherapy has ushered in a new era of cancer treatment, offering remarkable success against a...

Breast Cancer: Research & Awareness

Genetically Tailored Treatment Plans for Children with Kidney Cancer Promise Minimised Side Effects and Enhanced Efficacy

Billy Candra Sep 14, 2026

A landmark study has unveiled the intricate genetic underpinnings of Wilms tumour, a prevalent kidney...

Breaking Oncology News & General Research

Unveiling Breast Tumor’s Hidden Defenses: New Cellular Maps Reveal Dormant Cancer Cells and Their Protective Niches

Budi Oetomo Narendra Sep 14, 2026

A groundbreaking collaborative study by researchers from the MRC Laboratory of Medical Sciences (LMS), Imperial...

Breaking Oncology News & General Research

Breakthrough Unlocks 15-Year Mystery of Gut Toxin’s Role in Colorectal Cancer, Paving Way for Novel Therapeutic Strategies.

Budi Oetomo Narendra Sep 13, 2026

Scientists have achieved a significant milestone in understanding the intricate relationship between the human gut...

Immunotherapy & CAR-T Research

The Future Starts Here: Meet the 2025–2026 Postdoctoral Fellows

admin Sep 13, 2026

The Cancer Research Institute (CRI) has reaffirmed its profound commitment to advancing cancer immunotherapy by...

Breast Cancer: Research & Awareness

A Novel Approach to Breast Cancer Prevention: Bazedoxifene/Conjugated Estrogens Show Promise as Tamoxifen Alternative for High-Risk, Overweight Women

Billy Candra Sep 13, 2026

A significant proportion of women in the United States, particularly those between the ages of...

Lung Cancer & Thoracic Oncology

MD Anderson Researchers Identify STK11/KEAP1 Mutations as Key Biomarkers for Enhanced Immunotherapy Benefit in Advanced Lung Cancer

Lina carolina Sep 13, 2026

Researchers at The University of Texas MD Anderson Cancer Center have made a significant breakthrough...

Hematology, Leukemia & Lymphoma

Unveiling a New Axis of Immune Evasion: Hormone SCG2 and Receptor LILRB4 Collude to Shield Tumors

Hendra Lukman Sep 13, 2026

Researchers at UT Southwestern Medical Center have illuminated a critical mechanism by which cancer cells...

Gastrointestinal & Colorectal Cancers

Unlocking Pancreatic and Colorectal Cancer Resistance: Duke-NUS Scientists Identify Key Genetic Driver and New Therapeutic Avenue

Gilang Cahya Sep 13, 2026

Scientists at Duke-NUS Medical School have made a significant breakthrough in understanding why certain pancreatic...

Posts pagination

1 … 34 35 36 … 365

Posts Carousel

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

admin Sep 21, 2026
Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Hendra Lukman Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

George Ongkojoyo Sep 21, 2026
Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

admin Sep 21, 2026
Uncategorized

Welcoming Three New Leaders to the CureSearch Board of Directors

admin Sep 21, 2026
Trending
Popular
Latest
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026
Biotech, Pharma & Cancer Drug Development
Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment
Sep 21, 2026
Hematology, Leukemia & Lymphoma
Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests
Sep 21, 2026
Gynecologic Oncology (Ovarian, Cervical)
Bradyzoite subtypes rule the crossroads of Toxoplasma development
Sep 21, 2026
Pediatric Oncology & Childhood Cancers
Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund
Sep 21, 2026

You Missed

Biotech, Pharma & Cancer Drug Development

Telix Acquires ITM in $2.35 Billion Deal, Forging a Radiopharmaceutical Powerhouse in Cancer Treatment

Hematology, Leukemia & Lymphoma

Vitamin D2 Supplements May Undermine the Body’s Preferred Vitamin D Form, New Research Suggests

Gynecologic Oncology (Ovarian, Cervical)

Bradyzoite subtypes rule the crossroads of Toxoplasma development

Pediatric Oncology & Childhood Cancers

Glamorama Makes a Triumphant Return to Minneapolis Benefiting Children’s Cancer Research Fund

Cancerilles

Cancerilles

Knowledge and News for the Global Fight Against Cancer.

Copyright © All rights reserved | Newspaperup by Themeansar.

  • Home
  • About Us
    • About Us
    • Advertising Policy
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • DMCA
    • Privacy Policy
    • Terms of Service
  • Contact Us
  • FAQ
  • Sitemap

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.